LTBP-4 activators belong to a distinctive chemical class characterized by their specific molecular interactions with latent transforming growth factor beta-binding protein 4 (LTBP-4). LTBP-4 is a crucial component of the extracellular matrix, playing a fundamental role in the regulation of transforming growth factor beta (TGF-β) signaling. The activators exhibit a unique capacity to modulate LTBP-4, thereby influencing the activation and release of TGF-β. The LTBP-4 activators typically feature specialized structural motifs that enable them to bind selectively to LTBP-4, triggering conformational changes and facilitating the controlled release of TGF-β. These chemical entities act as molecular switches, orchestrating the finely tuned balance of TGF-β signaling within the cellular microenvironment.
Structurally, LTBP-4 activators often possess domains that interact with specific regions on LTBP-4, allowing for precise and targeted modulation of its functions. This interaction may involve the disruption of LTBP-4's latent complex with TGF-β, promoting the conversion of latent TGF-β to its active form. The activation of TGF-β is a pivotal event in various cellular processes, including cell proliferation, differentiation, and immune responses. Therefore, the identification and characterization of LTBP-4 activators provide valuable insights into the intricate regulatory mechanisms of TGF-β signaling. Understanding the structural basis and mechanisms of action of these activators contribute to the broader knowledge of cellular signaling pathways and may open avenues for the development of novel strategies to modulate TGF-β activity in a controlled manner.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
Alk5 Receptor Inhibitor; inhibits the TGF-β receptor Alk5, modulating TGF-β signaling and impacting LTBP-4 activation indirectly. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
ALK5 Inhibitor; inhibits ALK5, a TGF-β receptor, potentially influencing the TGF-β signaling pathway and activating LTBP-4. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Integrin Inhibitor; affects integrin-mediated TGF-β activation, indirectly influencing the activation of LTBP-4. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
Matrix Metalloproteinase Inhibitor; inhibits matrix metalloproteinases involved in TGF-β activation, potentially impacting LTBP-4 activation indirectly. | ||||||
SIS3 hydrochloride | 521984-48-5 | sc-253565 | 5 mg | $334.00 | 2 | |
SMAD3 Inhibitor; inhibits SMAD3, a downstream effector in the TGF-β pathway, indirectly impacting the activation of LTBP-4. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
Antioxidant; influences redox status, potentially affecting TGF-β signaling and activating LTBP-4 indirectly. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
HSP90 Inhibitor; inhibits HSP90, involved in TGF-β receptor folding, potentially activating LTBP-4 indirectly. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Wnt Pathway Inhibitor; inhibits the Wnt pathway, which interacts with TGF-β signaling, indirectly influencing the activation of LTBP-4. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB Inhibitor; inhibits NF-κB, which regulates TGF-β signaling, potentially activating LTBP-4 indirectly. | ||||||